Format
Sort by
Items per page

Send to

Choose Destination

Best matches for il-4 schizophrenia:

Search results

Items: 1 to 20 of 69

1.

Serum cytokine profile in schizophrenic patients.

Eftekharian MM, Omrani MD, Arsang-Jang S, Taheri M, Ghafouri-Fard S.

Hum Antibodies. 2018 Jul 14. doi: 10.3233/HAB-180344. [Epub ahead of print]

PMID:
30103309
2.

Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain.

Zhang J, Yang L, Fang Z, Kong J, Huang Q, Xu H.

J Neuroimmune Pharmacol. 2018 Sep;13(3):412-425. doi: 10.1007/s11481-018-9799-0. Epub 2018 Aug 1.

PMID:
30069711
3.

Maternal immune activation with staphylococcal enterotoxin A produces unique behavioral changes in C57BL/6 mouse offspring.

Glass R, Norton S, Fox N, Kusnecov AW.

Brain Behav Immun. 2018 May 14. pii: S0889-1591(18)30176-4. doi: 10.1016/j.bbi.2018.05.005. [Epub ahead of print]

PMID:
29772261
4.

Implications of altered maternal cytokine concentrations on infant outcomes in children with prenatal alcohol exposure.

Sowell KD, Uriu-Adams JY, Van de Water J, Chambers CD, Coles CD, Kable JA, Yevtushok L, Zymak-Zakutnya N, Wertelecki W, Keen CL; Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD).

Alcohol. 2018 May;68:49-58. doi: 10.1016/j.alcohol.2017.08.006. Epub 2017 Aug 12.

PMID:
29453023
5.

Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort.

Ntouros E, Karanikas E, Floros G, Andreou C, Tsoura A, Garyfallos G, Bozikas VP.

Cogn Neuropsychiatry. 2018 Mar;23(2):103-115. doi: 10.1080/13546805.2018.1440201. Epub 2018 Feb 15.

PMID:
29447074
6.

Characterization of macrophages from schizophrenia patients.

Ormel PR, van Mierlo HC, Litjens M, Strien MEV, Hol EM, Kahn RS, de Witte LD.

NPJ Schizophr. 2017 Nov 14;3(1):41. doi: 10.1038/s41537-017-0042-4.

7.

Evidence for Hypothalamus-Pituitary-Adrenal Axis and Immune Alterations at Prodrome of Psychosis in Males.

Karanikas E, Ntouros E, Oikonomou D, Floros G, Griveas I, Garyfallos G.

Psychiatry Investig. 2017 Sep;14(5):703-707. doi: 10.4306/pi.2017.14.5.703. Epub 2017 Sep 11.

8.

Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients.

Wei L, Du Y, Wu W, Fu X, Xia Q.

J Affect Disord. 2018 Jan 15;226:307-312. doi: 10.1016/j.jad.2017.10.002. Epub 2017 Oct 3.

PMID:
29028592
9.

The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.

Kageyama Y, Kasahara T, Kato M, Sakai S, Deguchi Y, Tani M, Kuroda K, Hattori K, Yoshida S, Goto Y, Kinoshita T, Inoue K, Kato T.

J Affect Disord. 2018 Jun;233:15-20. doi: 10.1016/j.jad.2017.06.001. Epub 2017 Jun 6.

10.

Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders.

Custódio CS, Mello BSF, Filho AJMC, de Carvalho Lima CN, Cordeiro RC, Miyajima F, Réus GZ, Vasconcelos SMM, Barichello T, Quevedo J, de Oliveira AC, de Lucena DF, Macedo DS.

Mol Neurobiol. 2018 May;55(5):3775-3788. doi: 10.1007/s12035-017-0616-1. Epub 2017 May 23.

PMID:
28536974
11.

Effects of the modified electric convulsive treatment (MECT) on cell factors of schizophrenia.

Guo YF, Fu HB, Liu ZY, Lu W, Luo KY, Zhu HR, Ning WD, Chen F, Yang LY, Zhou XD.

Exp Ther Med. 2017 Mar;13(3):873-876. doi: 10.3892/etm.2017.4075. Epub 2017 Jan 20.

12.

The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.

Canever L, Alves CSV, Mastella G, Damázio L, Polla JV, Citadin S, De Luca LA, Barcellos AS, Garcez ML, Quevedo J, Budni J, Zugno AI.

Mol Neurobiol. 2018 Mar;55(3):2301-2319. doi: 10.1007/s12035-017-0493-7. Epub 2017 Mar 24.

PMID:
28342013
13.

Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.

Szymona K, Zdzisińska B, Karakuła-Juchnowicz H, Kocki T, Kandefer-Szerszeń M, Flis M, Rosa W, Urbańska EM.

Neurotox Res. 2017 Jul;32(1):17-26. doi: 10.1007/s12640-017-9714-0. Epub 2017 Mar 8.

PMID:
28275903
14.

Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms.

de Campos-Carli SM, Araújo MS, de Oliveira Silveira AC, de Rezende VB, Rocha NP, Ferretjans R, Ribeiro-Santos R, Teixeira-Carvalho A, Martins-Filho OA, Berk M, Salgado JV, Teixeira AL.

J Psychiatr Res. 2017 Apr;87:44-52. doi: 10.1016/j.jpsychires.2016.12.001. Epub 2016 Dec 3.

PMID:
28011441
15.

Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation.

Rose DR, Careaga M, Van de Water J, McAllister K, Bauman MD, Ashwood P.

Brain Behav Immun. 2017 Jul;63:60-70. doi: 10.1016/j.bbi.2016.11.020. Epub 2016 Nov 19.

16.

Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia.

Balõtšev R, Koido K, Vasar V, Janno S, Kriisa K, Mahlapuu R, Ljubajev U, Parksepp M, Veiksaar P, Volke V, Lang A, Haring L, Zilmer M, Vasar E.

Eur Psychiatry. 2017 Jan;39:1-10. doi: 10.1016/j.eurpsy.2016.05.010. Epub 2016 Nov 1.

PMID:
27810612
17.

Exercise-induced modulation of histone H4 acetylation status and cytokines levels in patients with schizophrenia.

Lavratti C, Dorneles G, Pochmann D, Peres A, Bard A, de Lima Schipper L, Dal Lago P, Wagner LC, Elsner VR.

Physiol Behav. 2017 Jan 1;168:84-90. doi: 10.1016/j.physbeh.2016.10.021. Epub 2016 Oct 31.

PMID:
27810494
18.

IL-4, TGF-, NF-B and MPO levels in Patients with Treatment Resistant Schizophrenia.

Kartalcı Ş, Gönenir Erbay L, Porgalı Zayman E, Otlu Ö, Bay Karabulut A, Kartalcı G.

Turk Psikiyatri Derg. 2016 Fall;27(3):170-175. Turkish, English.

19.

Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.

da Silva Araújo T, Maia Chaves Filho AJ, Monte AS, Isabelle de Góis Queiroz A, Cordeiro RC, de Jesus Souza Machado M, de Freitas Lima R, Freitas de Lucena D, Maes M, Macêdo D.

J Psychiatr Res. 2017 Jan;84:49-58. doi: 10.1016/j.jpsychires.2016.09.017. Epub 2016 Sep 21.

PMID:
27697587
20.

Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.

Zeni-Graiff M, Rizzo LB, Mansur RB, Maurya PK, Sethi S, Cunha GR, Asevedo E, Pan P, Zugman A, Yamagata AS, Higuchi C, Bressan RA, Gadelha A, Brietzke E.

Schizophr Res. 2016 Oct;176(2-3):191-195. doi: 10.1016/j.schres.2016.06.031. Epub 2016 Aug 8.

PMID:
27424266

Supplemental Content

Loading ...
Support Center